Cell And Gene Therapy Manufacturing Market Competitive Landscape

Executive Summary

• Market Overview
• Key Findings
• Market Size and Growth Projections
  
  • Market Value
  • Market Volume
• Key Market Trends
• Competitive Landscape Summary

Introduction

• Market Definition
• Research Methodology
• Scope of the Report
• Assumptions and Limitations

Market Dynamics

• Market Drivers
  
  • Advances in Cell and Gene Therapy Technologies
  • Increasing Incidence of Chronic Diseases
  • Rising Investments in Cell and Gene Therapy Research
• Market Restraints
  
  • High Cost of Therapy Development
  • Regulatory Challenges
• Market Opportunities
  
  • Emerging Markets
  • Technological Innovations
• Market Challenges
  
  • Manufacturing Complexities
  • Supply Chain Issues

Market Segmentation

• By Therapy Type
  • Allogeneic Cell Therapy
  • Autologous Cell Therapy
• By Technology Type
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • 3D Technology
• By Source
  • Umbilical Cord
  • Neural Stem
  • Bone Marrow
  • Adipose Tissue
  • IPSC's (Induced Pluripotent Stem Cell)
• By Application
  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Market's Cross Sectional Segmentations

By Therapy Type

• Allogeneic Cell Therapy
  • Market Value: Revenue generated from manufacturing and commercializing allogeneic cell therapies.
  • Market Volume: Quantity of allogeneic cell therapies produced and administered.
  • Cross-Segmentation Analysis:
    
    • By Technology Type:
      
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Autologous Cell Therapy
  • Market Value: Revenue from autologous cell therapies.
  • Market Volume: Quantity of autologous cell therapies produced and used.
  • Cross-Segmentation Analysis:
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa

By Technology Type

• Somatic Cell Technology
  • Market Value: Revenue from the use of somatic cell technology in cell and gene therapy manufacturing.
  • Market Volume: Quantity of therapies using somatic cell technology.
  • Cross-Segmentation Analysis:
    
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Cell Immortalization Technology
  • Market Value: Revenue from cell immortalization technology.
  • Market Volume: Quantity of therapies using cell immortalization technology.
  • Cross-Segmentation Analysis:
    
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
      • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Viral Vector Technology
  • Market Value: Revenue from viral vector technology.
  • Market Volume: Quantity of therapies utilizing viral vector technology.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Genome Editing Technology
  • Market Value: Revenue from genome editing technologies.
  • Market Volume: Quantity of therapies using genome editing technologies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Cell Plasticity Technology
  • Market Value: Revenue from cell plasticity technologies.
  • Market Volume: Quantity of therapies using cell plasticity technologies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• 3D Technology
  • Market Value: Revenue from 3D technologies in cell and gene therapy.
  • Market Volume: Quantity of therapies developed using 3D technologies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa

By Source

• Umbilical Cord
  • Market Value: Revenue from therapies using umbilical cord-derived cells.
  • Market Volume: Quantity of umbilical cord-derived therapies.
  • Cross-Segmentation Analysis: 
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Neural Stem
  • Market Value: Revenue from neural stem cell therapies.
  • Market Volume: Quantity of neural stem cell therapies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Bone Marrow
  • Market Value: Revenue from bone marrow-derived cell therapies.
  • Market Volume: Quantity of bone marrow-derived therapies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Adipose Tissue
  • Market Value: Revenue from adipose tissue-derived cell therapies.
  • Market Volume: Quantity of adipose tissue-derived therapies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• IPSCs (Induced Pluripotent Stem Cells)
  • Market Value: Revenue from IPSCs-based therapies.
  • Market Volume: Quantity of IPSCs-based therapies.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa

By Application

• Musculoskeletal
  • Market Value: Revenue from musculoskeletal application therapies.
  • Market Volume: Quantity of therapies for musculoskeletal applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Cardiovascular
  • Market Value: Revenue from cardiovascular application therapies.
  • Market Volume: Quantity of therapies for cardiovascular applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Gastrointestinal
  • Market Value: Revenue from gastrointestinal application therapies.
  • Market Volume: Quantity of therapies for gastrointestinal applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Neurological
  • Market Value: Revenue from neurological application therapies.
  • Market Volume: Quantity of therapies for neurological applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Oncology
  • Market Value: Revenue from oncology application therapies.
  • Market Volume: Quantity of therapies for oncology applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • • Allogeneic Cell Therapy
        • Autologous Cell Therapy
      • By Technology Type:
        • Somatic Cell Technology
        • Cell Immortalization Technology
        • Viral Vector Technology
        • Genome Editing Technology
        • Cell Plasticity Technology
        • 3D Technology
      • By Source:
        • Umbilical Cord
        • Neural Stem
        • Bone Marrow
        • Adipose Tissue
        • IPSCs (Induced Pluripotent Stem Cells)
      • By Region:
        • North America
        • Europe
        • Asia Pacific
        • Latin America
        • Middle East
        • Africa
• Dermatology
  • Market Value: Revenue from dermatology application therapies.
  • Market Volume: Quantity of therapies for dermatology applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa
• Others
  • Market Value: Revenue from other application areas not specified above.
  • Market Volume: Quantity of therapies for other applications.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Region:
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East
      • Africa

By Region

• North America
  • Market Value: Total revenue from cell and gene therapy manufacturing in North America.
  • Market Volume: Quantity of therapies produced and administered in North America.
  • Cross-Segmentation Analysis:
    
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
• Europe
  • Market Value: Total revenue from cell and gene therapy manufacturing in Europe.
  • Market Volume: Quantity of therapies produced and administered in Europe.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
• Asia Pacific
  • Market Value: Total revenue from cell and gene therapy manufacturing in Asia Pacific.
  • Market Volume: Quantity of therapies produced and administered in Asia Pacific.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
• Latin America
  • Market Value: Total revenue from cell and gene therapy manufacturing in Latin America.
  • Market Volume: Quantity of therapies produced and administered in Latin America.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
• Middle East
  • Market Value: Total revenue from cell and gene therapy manufacturing in the Middle East.
  • Market Volume: Quantity of therapies produced and administered in the Middle East.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others
• Africa
  • Market Value: Total revenue from cell and gene therapy manufacturing in Africa.
  • Market Volume: Quantity of therapies produced and administered in Africa.
  • Cross-Segmentation Analysis:
    • By Therapy Type:
      • Allogeneic Cell Therapy
      • Autologous Cell Therapy
    • By Technology Type:
      • Somatic Cell Technology
      • Cell Immortalization Technology
      • Viral Vector Technology
      • Genome Editing Technology
      • Cell Plasticity Technology
      • 3D Technology
    • By Source:
      • Umbilical Cord
      • Neural Stem
      • Bone Marrow
      • Adipose Tissue
      • IPSCs (Induced Pluripotent Stem Cells)
    • By Application:
      • Musculoskeletal
      • Cardiovascular
      • Gastrointestinal
      • Neurological
      • Oncology
      • Dermatology
      • Others

Competitive Landscape

• Market Share Analysis
• Key Player Profiles
• Bluebird Bio Inc.
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
  • Strategies
• Hitachi Chemical Co., Ltd.
• Takara Bio Inc.
• Catalent Inc.
• F. Hoffmann-La Roche Ltd.
• Samsung Biologics
• Novartis AG
• Lonza
• Merck KGaA
• Wuxi Advanced Therapies
• Boehringer Ingelheim
• Cellular Therapeutics
• Miltenyi Biotec
• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Bluebird Bio Inc.
• Competitive Benchmarking

Market Trends and Opportunities

• Technological Advancements in Manufacturing
• Collaborations and Partnerships
• Expanding Pipeline of Cell and Gene Therapies
• Regulatory Approvals and Updates

Supply Chain Analysis

• Raw Material Suppliers
• Manufacturing Process
• Distribution Channels
• End-User Analysis

Regulatory Landscape

• Overview of Regulatory Bodies
• Key Regulations and Guidelines
• Impact of Regulations on Market Growth

Case Studies

• Successful Cell and Gene Therapy Manufacturing Projects
• Challenges and Solutions in Manufacturing

Future Outlook

• Market Forecast
  • Forecast by Therapy Type
  • Forecast by Technology Type
  • Forecast by Source
  • Forecast by Application
  • Forecast by Region
• Emerging Trends
• Strategic Recommendations for Stakeholders

Appendix

• List of Abbreviations
• Glossary of Terms
• Research Methodology
• References
• Contact Information